Table 1. Patient Characteristics.

	Dose Level 1 (n=8)	Dose Level 2 (n=9)	Dose Level 3 (n=8)
Age (years)
Median	58	57	57
Min - Max	39 - 72	39 - 69	31 – 73
Q1 - Q3	51.5 - 68.5	52 - 63	51.5 – 67
Gender
Male	4 (50.0%)	8 (88.9%)	2 (25.0%)
Female	4 (50.0%)	1 (11.1%)	6 (75.0%)
Race
Native Hawaiian or Other Pacific	0 (0.0%)	0 (0.0%)	1 (12.5%)
Islander
White	8 (100.0%)	9 (100.0%)	7 (87.5%)
Ethnicity
Hispanic or Latino	0 (0.0%)	0 (0.0%)	1 (12.5%)
Not Hispanic or Latino	7 (87.5%)	8 (88.9%)	7 (87.5%)
Unknown (Individuals not reporting ethnicity)	1 (12.5%)	1 (11.1%)	0 (0.0%)
KPS
70-80	3 (37.5%)	4 (44.4%)	3 (37.5%)
90-100	5 (62.5%)	5 (55.6%)	5 (62.5%)
Surgery
Subtotal	2 (25.0%)	3 (33.3%)	4 (50.0%)
Total (gross)	6 (75.0%)	5 (55.6%)	4 (50.0%)
Other	0 (0.0%)	1 (11.1%)	0 (0.0%)
Neurologic Function
No symptoms	2 (25.0%)	3 (33.3%)	3 (37.5%)
Minor symptoms	6 (75.0%)	5 (55.6%)	5 (62.5%)
Moderate symptoms	0 (0.0%)	1 (11.1%)	0 (0.0%)
RPA Class
III	2 (25.0%)	1 (11.1%)	1 (12.5%)
IV	6 (75.0%)	7 (77.8%)	7 (87.5%)
V	0 (0.0%)	1 (11.1%)	0 (0.0%)

Q1 = first quartile; Q3 = third quartile.

RPA = Recursive Partitioning Analysis.